• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

U-CAN-seq:一种基于纳米孔测序的通用竞争检测方法。

U-CAN-seq: A Universal Competition Assay by Nanopore Sequencing.

作者信息

Diaz Jennifer, Sears John, Chang Che-Kang, Burdick Jane, Law Isabella, Sanders Wes, Linnertz Colton, Sylvester Paul, Moorman Nathaniel, Ferris Martin T, Heise Mark T

机构信息

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.

出版信息

Viruses. 2024 Apr 19;16(4):636. doi: 10.3390/v16040636.

DOI:10.3390/v16040636
PMID:38675976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11054411/
Abstract

RNA viruses quickly evolve subtle genotypic changes that can have major impacts on viral fitness and host range, with potential consequences for human health. It is therefore important to understand the evolutionary fitness of novel viral variants relative to well-studied genotypes of epidemic viruses. Competition assays are an effective and rigorous system with which to assess the relative fitness of viral genotypes. However, it is challenging to quickly and cheaply distinguish and quantify fitness differences between very similar viral genotypes. Here, we describe a protocol for using reverse transcription PCR in combination with commercial nanopore sequencing services to perform competition assays on untagged RNA viruses. Our assay, called the Universal Competition Assay by Nanopore Sequencing (U-CAN-seq), is relatively cheap and highly sensitive. We used a well-studied N24A mutation in the chikungunya virus (CHIKV) nsp3 gene to confirm that we could detect a competitive disadvantage using U-CAN-seq. We also used this approach to show that mutations to the CHIKV 5' conserved sequence element that disrupt sequence but not structure did not affect the fitness of CHIKV. However, similar mutations to an adjacent CHIKV stem loop (SL3) did cause a fitness disadvantage compared to wild-type CHIKV, suggesting that structure-independent, primary sequence determinants in this loop play an important role in CHIKV biology. Our novel findings illustrate the utility of the U-CAN-seq competition assay.

摘要

RNA病毒会迅速发生细微的基因型变化,这些变化可能对病毒适应性和宿主范围产生重大影响,进而对人类健康造成潜在后果。因此,了解新型病毒变体相对于已深入研究的流行病毒基因型的进化适应性非常重要。竞争试验是评估病毒基因型相对适应性的一种有效且严格的系统。然而,快速且低成本地区分和量化非常相似的病毒基因型之间的适应性差异具有挑战性。在此,我们描述了一种将逆转录PCR与商业纳米孔测序服务相结合的方案,用于对未标记的RNA病毒进行竞争试验。我们的试验称为纳米孔测序通用竞争试验(U-CAN-seq),相对成本较低且灵敏度高。我们利用在基孔肯雅病毒(CHIKV)nsp3基因中一个已深入研究的N24A突变,证实我们能够通过U-CAN-seq检测到竞争劣势。我们还使用这种方法表明,CHIKV 5'保守序列元件发生的破坏序列但不破坏结构的突变不会影响CHIKV的适应性。然而,与相邻的CHIKV茎环(SL3)发生的类似突变相比野生型CHIKV确实导致了适应性劣势,这表明该环中与结构无关的一级序列决定因素在CHIKV生物学中起重要作用。我们的新发现说明了U-CAN-seq竞争试验的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/f64f4e97c675/viruses-16-00636-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/45bf76282c13/viruses-16-00636-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/71f834e28287/viruses-16-00636-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/f64f4e97c675/viruses-16-00636-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/45bf76282c13/viruses-16-00636-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/71f834e28287/viruses-16-00636-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b10/11054411/f64f4e97c675/viruses-16-00636-g003.jpg

相似文献

1
U-CAN-seq: A Universal Competition Assay by Nanopore Sequencing.U-CAN-seq:一种基于纳米孔测序的通用竞争检测方法。
Viruses. 2024 Apr 19;16(4):636. doi: 10.3390/v16040636.
2
Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells.随机密码子重编码可稳定降低基孔肯雅病毒在灵长类动物和蚊子细胞中的复制适应性。
PLoS Pathog. 2013 Feb;9(2):e1003172. doi: 10.1371/journal.ppat.1003172. Epub 2013 Feb 21.
3
A 44-Nucleotide Region in the Chikungunya Virus 3' UTR Dictates Viral Fitness in Disparate Host Cells.一个 44 个核苷酸的区域在基孔肯雅病毒 3'UTR 决定病毒在不同宿主细胞中的适应性。
Viruses. 2024 May 28;16(6):861. doi: 10.3390/v16060861.
4
Copy number variation of Chikungunya ECSA virus with disease symptoms among Indian patients.印度患者具有疾病症状的基孔肯雅热 ECSA 病毒的拷贝数变异。
J Med Virol. 2014 Aug;86(8):1386-92. doi: 10.1002/jmv.23794. Epub 2013 Oct 16.
5
Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.利用哺乳动物和蚊子 RNA 聚合酶 I 介导的转录设计和使用基孔肯雅病毒复制模板。
J Virol. 2019 Aug 28;93(18). doi: 10.1128/JVI.00794-19. Print 2019 Sep 15.
6
Using SHAPE-MaP To Model RNA Secondary Structure and Identify 3'UTR Variation in Chikungunya Virus.利用 SHAPE-MaP 构建模型以研究基孔肯雅病毒的 RNA 二级结构和鉴定 3'UTR 变异。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00701-20.
7
Genetic Diversity and Spatiotemporal Dynamics of Chikungunya Infections in Mexico during the Outbreak of 2014-2016.2014-2016 年墨西哥基孔肯雅热疫情期间的遗传多样性和时空动态。
Viruses. 2021 Dec 31;14(1):70. doi: 10.3390/v14010070.
8
Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice.基孔肯雅病毒保真度变异体在细胞培养和成年小鼠中表现出不同的衰减和种群多样性。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.01606-18. Print 2019 Feb 1.
9
Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.新型 nsP2 突变消除了基孔肯雅病毒诱导的转录关闭,并降低了病毒的细胞病变效应而不影响其复制率。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.02062-18. Print 2019 Feb 15.
10
Large-scale outbreak of Chikungunya virus infection in Thailand, 2018-2019.2018-2019 年泰国大规模基孔肯雅热病毒感染疫情。
PLoS One. 2021 Mar 10;16(3):e0247314. doi: 10.1371/journal.pone.0247314. eCollection 2021.

本文引用的文献

1
Nanopore sequencing technology and its applications.纳米孔测序技术及其应用。
MedComm (2020). 2023 Jul 10;4(4):e316. doi: 10.1002/mco2.316. eCollection 2023 Aug.
2
Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR.比较多重实时 PCR 鉴定 SARS-CoV-2 关注变异株的不同测序技术。
PLoS One. 2022 Apr 4;17(4):e0265220. doi: 10.1371/journal.pone.0265220. eCollection 2022.
3
Nanopore sequencing technology, bioinformatics and applications.纳米孔测序技术、生物信息学及其应用。
Nat Biotechnol. 2021 Nov;39(11):1348-1365. doi: 10.1038/s41587-021-01108-x. Epub 2021 Nov 8.
4
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics.RNA 病毒遗传学中的突变率、突变频率和校对修复活性。
Viruses. 2021 Sep 21;13(9):1882. doi: 10.3390/v13091882.
5
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.在体外筛选瑞德西韦耐药性表明了 SARS-CoV-2 的进化可预测性。
PLoS Pathog. 2021 Sep 17;17(9):e1009929. doi: 10.1371/journal.ppat.1009929. eCollection 2021 Sep.
6
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.评估在竞争混合雪貂模型中具有降低的巴洛沙韦敏感性的 PA/I38T 取代流感 A 病毒的适应性。
PLoS Pathog. 2021 May 6;17(5):e1009527. doi: 10.1371/journal.ppat.1009527. eCollection 2021 May.
7
Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion.定量测量单细胞中早期甲病毒复制动力学,揭示了超级感染排斥的基础。
Cell Syst. 2021 Mar 17;12(3):210-219.e3. doi: 10.1016/j.cels.2020.12.005. Epub 2021 Jan 29.
8
Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design.通过基于片段的药物设计靶向基孔肯雅病毒nsP3大结构域的嘧啶酮抑制剂。
PLoS One. 2021 Jan 22;16(1):e0245013. doi: 10.1371/journal.pone.0245013. eCollection 2021.
9
Using SHAPE-MaP To Model RNA Secondary Structure and Identify 3'UTR Variation in Chikungunya Virus.利用 SHAPE-MaP 构建模型以研究基孔肯雅病毒的 RNA 二级结构和鉴定 3'UTR 变异。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00701-20.
10
Construction of Stable Reporter Flaviviruses and Their Applications.稳定报告型黄病毒的构建及其应用。
Viruses. 2020 Sep 25;12(10):1082. doi: 10.3390/v12101082.